Docusign, Inc.: Form 10-Q for the period ended Apr 30, 2021
Filed with the SEC on Jun 4, 2021 and accepted by EDGAR at Jun 4, 2021, 16:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-02-01 to 2021-04-30 | $469.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-02-01 to 2021-04-30 | $105.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-02-01 to 2021-04-30 | $363.8m | us-gaap:GrossProfit |
| Research and development | 3 months2021-02-01 to 2021-04-30 | $85.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-02-01 to 2021-04-30 | −$10.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-02-01 to 2021-04-30 | $1.7m | us-gaap:InterestExpense |
| Income tax | 3 months2021-02-01 to 2021-04-30 | $2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-02-01 to 2021-04-30 | −$8.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-02-01 to 2021-04-30 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-02-01 to 2021-04-30 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-02-01 to 2021-04-30 | 194,342,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2021-02-01 to 2021-04-30 | $135.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-02-01 to 2021-04-30 | $12.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-04-30 | $519.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-04-30 | $1.11bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-04-30 | $2.30bn | us-gaap:Assets |
| Current liabilities | At period end2021-04-30 | $1.10bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-04-30 | $2.05bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-04-30 | $243.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001261333-21-000108. Last ingested by Listed: Nov 5, 2026, 13:21 ET. Listed shows no prices and gives no investment advice.